BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7181485)

  • 1. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.
    Hallander HO; Dornbusch K; Gezelius L; Jacobson K; Karlsson I
    Antimicrob Agents Chemother; 1982 Nov; 22(5):743-52. PubMed ID: 7181485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I; Nagy E
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Yu PK; Edson RS; Washington JA; Hermans PE
    Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
    Fosse T; Soussy CJ; Duval J
    Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.
    Yamashita K; Kawabe H; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jul; 20(1):33-7. PubMed ID: 6792980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
    Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
    Bayer AS; Eisenstadt R; Morrison JO
    Antimicrob Agents Chemother; 1984 Jun; 25(6):725-8. PubMed ID: 6331297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).
    Yu VL; Vickers RM; Zuravleff JJ
    Antimicrob Agents Chemother; 1980 Jan; 17(1):96-8. PubMed ID: 6766295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosa.
    Madaras-Kelly KJ; Moody J; Larsson A; Baeker Hovde L; Rotschafer JC
    Chemotherapy; 1997; 43(2):108-17. PubMed ID: 9084919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A statistical evaluation of the bactericidal effects of ceftibuten in combination with aminoglycosides and ciprofloxacin.
    Guérillot F; Carret G; Flandrois JP
    J Antimicrob Chemother; 1993 Nov; 32(5):685-94. PubMed ID: 8125833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.